Cargando…
Effect of folylpolyglutamate synthase A22G polymorphism on the risk and survival of patients with acute lymphoblastic leukemia
Folylpolyglutamate synthase (FPGS) is the key enzyme that converts the chemotherapeutic agent, methotrexate (MTX), into MTX polyglutamate. An A22G polymorphism has been found in the FPGS gene. This study aimed to evaluated whether the A22G polymorphism in the FPGS gene is associated with an increase...
Autores principales: | GÓMEZ-GÓMEZ, YAZMÍN, ORGANISTA-NAVA, JORGE, RANGEL-RODRIGUEZ, CARLOS ALBERTO, ILLADES-AGUIAR, BERENICE, MORENO-GODÍNEZ, MARÍA ELENA, ALARCÓN-ROMERO, LUZ DEL CARMEN, LEYVA-VÁZQUEZ, MARCO ANTONIO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081359/ https://www.ncbi.nlm.nih.gov/pubmed/25013492 http://dx.doi.org/10.3892/ol.2014.2175 |
Ejemplares similares
-
Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia
por: Organista-Nava, Jorge, et al.
Publicado: (2018) -
Plasma levels of YKL-40 as a prognostic factor in childhood acute lymphoblastic leukemia
por: Rivas-Alarcón, Alinne Ayulieth, et al.
Publicado: (2021) -
High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia
por: ORGANISTA-NAVA, JORGE, et al.
Publicado: (2015) -
Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer
por: Organista-Nava, Jorge, et al.
Publicado: (2019) -
Role of Oct3/4 in Cervical Cancer Tumorigenesis
por: Clemente-Periván, Sayuri Itzel, et al.
Publicado: (2020)